| MRI-targeted or standard biopsy for prostate-cancer diagnosis V Kasivisvanathan, AS Rannikko, M Borghi, V Panebianco, LA Mynderse, ... New England Journal of Medicine 378 (19), 1767-1777, 2018 | 2834 | 2018 |
| Image-guided prostate biopsy using magnetic resonance imaging–derived targets: a systematic review CM Moore, NL Robertson, N Arsanious, T Middleton, A Villers, L Klotz, ... European urology 63 (1), 125-140, 2013 | 678 | 2013 |
| Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group CM Moore, V Kasivisvanathan, S Eggener, M Emberton, JJ Fütterer, ... European urology 64 (4), 544-552, 2013 | 468 | 2013 |
| Weakly-supervised convolutional neural networks for multimodal image registration Y Hu, M Modat, E Gibson, W Li, N Ghavami, E Bonmati, G Wang, ... Medical image analysis 49, 1-13, 2018 | 426 | 2018 |
| Photodynamic therapy for prostate cancer—a review of current status and future promise CM Moore, D Pendse, M Emberton Nature clinical practice Urology 6 (1), 18-30, 2009 | 391 | 2009 |
| Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review IG Schoots, N Petrides, F Giganti, LP Bokhorst, A Rannikko, L Klotz, ... European urology 67 (4), 627-636, 2015 | 379 | 2015 |
| Multiparametric MRI for prostate cancer diagnosis: current status and future directions A Stabile, F Giganti, AB Rosenkrantz, SS Taneja, G Villeirs, IS Gill, C Allen, ... Nature reviews urology 17 (1), 41-61, 2020 | 311 | 2020 |
| A multicentre study of 5-year outcomes following focal therapy in treating clinically significant nonmetastatic prostate cancer S Guillaumier, M Peters, M Arya, N Afzal, S Charman, T Dudderidge, ... European urology 74 (4), 422-429, 2018 | 293 | 2018 |
| Focal therapy: patients, interventions, and outcomes—a report from a consensus meeting IA Donaldson, R Alonzi, D Barratt, E Barret, V Berge, S Bott, D Bottomley, ... European urology 67 (4), 771-777, 2015 | 260 | 2015 |
| Reporting magnetic resonance imaging in men on active surveillance for prostate cancer: the PRECISE recommendations—a report of a European School of Oncology Task Force CM Moore, F Giganti, P Albertsen, C Allen, C Bangma, A Briganti, ... European urology 71 (4), 648-655, 2017 | 249 | 2017 |
| Negative predictive value of multiparametric magnetic resonance imaging in the detection of clinically significant prostate cancer in the prostate imaging reporting and data … NJ Sathianathen, A Omer, E Harriss, L Davies, V Kasivisvanathan, ... European urology 78 (3), 402-414, 2020 | 244 | 2020 |
| Transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer V Kasivisvanathan, R Dufour, CM Moore, HU Ahmed, M Abd-Alazeez, ... The Journal of urology 189 (3), 860-866, 2013 | 227 | 2013 |
| Prostate Imaging Quality (PI-QUAL): a new quality control scoring system for multiparametric magnetic resonance imaging of the prostate from the PRECISION trial F Giganti, C Allen, M Emberton, CM Moore, V Kasivisvanathan, ... European urology oncology 3 (5), 615-619, 2020 | 209 | 2020 |
| Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease JH Yun, A Lamb, R Chase, D Singh, MM Parker, A Saferali, J Vestbo, ... Journal of allergy and clinical immunology 141 (6), 2037-2047. e10, 2018 | 209 | 2018 |
| Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer CM Moore, TR Nathan, WR Lees, CA Mosse, A Freeman, M Emberton, ... Lasers in Surgery and Medicine: The Official Journal of the American Society …, 2006 | 205 | 2006 |
| Magnetic resonance imaging-targeted biopsy versus systematic biopsy in the detection of prostate cancer: a systematic review and meta-analysis V Kasivisvanathan, A Stabile, JB Neves, F Giganti, M Valerio, ... European urology 76 (3), 284-303, 2019 | 203 | 2019 |
| Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation cohort study with transperineal template prostate mapping as the reference standard N Arumainayagam, HU Ahmed, CM Moore, A Freeman, C Allen, ... Radiology 268 (3), 761-769, 2013 | 197 | 2013 |
| TOOKAD® Soluble vascular‐targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with … AR Azzouzi, E Barret, CM Moore, A Villers, C Allen, A Scherz, G Muir, ... BJU international 112 (6), 766-774, 2013 | 189 | 2013 |
| Label-driven weakly-supervised learning for multimodal deformable image registration Y Hu, M Modat, E Gibson, N Ghavami, E Bonmati, CM Moore, M Emberton, ... 2018 IEEE 15th International Symposium on Biomedical Imaging (ISBI 2018 …, 2018 | 181 | 2018 |
| Active surveillance for prostate cancer: a narrative review of clinical guidelines SM Bruinsma, CH Bangma, PR Carroll, MS Leapman, A Rannikko, ... Nature Reviews Urology 13 (3), 151-167, 2016 | 180 | 2016 |
Mark EmbertonProfessor of Interventional Oncology, University College London, UK在 ucl.ac.uk 的电子邮件经过验证
